At a glance
| Chemical family | A retinoid — the natural, alcohol form of vitamin A used in over-the-counter cosmetics (distinct from prescription retinoic-acid drugs like tretinoin) |
| CAS number | 68-26-8 |
| Classification | Not IARC-classified — retinol does not appear in any IARC Group (1, 2A, 2B, or 3); it has never been evaluated for carcinogenicity by IARC. EU SCCS judges it safe in cosmetics within defined concentration limits |
| Where you encounter it | Over-the-counter night creams, serums and anti-aging moisturizers, almost always marketed and used as a bedtime step |
| Sleep micro-environment relevance | A leave-on skin product applied immediately before sleep; light-unstable, so night use is the norm; residue transfers onto pillowcases and sheets |
| Activated carbon capture | Not the lever — this is a skin-and-fabric residue, not an airborne emission; product choice, dosing and laundering are what matter |
Regulatory & certification status
Where retinol stands across the major regulatory systems. Each row links to the governing instrument; where a jurisdiction has no specific measure, that is stated plainly rather than left blank.
| European Union | Commission Regulation (EU) 2024/996 (3 April 2024) amended the Cosmetics Regulation (EC) 1223/2009, adding retinol, retinyl acetate and retinyl palmitate to Annex III (restricted substances) with maximum concentrations of 0.05% Retinol Equivalent (RE) in body lotion and 0.3% RE in other leave-on and rinse-off products, plus a mandatory label statement: "Contains vitamin A. Consider your daily intake before use." The restriction applies to new products from 1 November 2025 and to products already on the market from 1 May 2027. It followed EU SCCS Opinion SCCS/1639/21 (final 24–25 October 2022), which judged those concentrations safe but flagged that cosmetic exposure adds to total vitamin A intake, which may already be high for the most-exposed 5% of consumers from diet and supplements alone. Regulatory — EU SCCS Opinion SCCS/1639/21 |
| United States | Retinol is not on the California Proposition 65 list and is not subject to an FDA concentration cap; the FDA regulates OTC retinol cosmetics as cosmetics (not drugs) under general cosmetic-safety authority, and does not set a numeric maximum percentage the way the EU now does. Prescription-strength retinoic acid (tretinoin) is regulated separately as an FDA-approved drug. Regulatory — inferred from absence of a listing; no primary US concentration-limit regulation identified for cosmetic retinol Inferred — absence of a specific rule is itself the finding here, not a gap in research |
| International — IARC | Retinol / vitamin A (CAS 68-26-8) does not appear anywhere in IARC's cumulative list of classified agents (Groups 1, 2A, 2B, 3). It has never been evaluated by the IARC Monographs carcinogen-classification program. This is distinct from a Group 3 ("not classifiable") finding, which would mean IARC looked and found the evidence inconclusive — for retinol, no evaluation exists at all. Note: IARC's separate Handbooks of Cancer Prevention series (Volume 4, 1999, "Retinoids") evaluated nine different, synthetic prescription retinoid drugs (e.g., all-trans-retinoic acid, etretinate, acitretin) for cancer-preventive potential — a different program assessing different molecules for a different endpoint, not a carcinogenicity classification of retinol. Regulatory — IARC Monographs — Agents Classified |
| Certifications | Retinol is not addressed by CertiPUR-US (foam emissions), OEKO-TEX Standard 100 (textiles), or GREENGUARD (low-emission products) — all three are scoped to materials and off-gassing, not leave-on cosmetic actives. It falls outside all three programs. Industry — CertiPUR-US · OEKO-TEX |
| The 72-hour test window | Not applicable. Retinol is a non-volatile cosmetic active applied to skin, not a mattress-material off-gassing compound, so a VOC chamber emissions test would not be the relevant screen for it. Inferred — from the compound's use pattern and non-volatile chemistry |
What it is
Retinol is the alcohol form of vitamin A and the most common over-the-counter retinoid in skincare — sold in night creams, serums, and anti-aging moisturizers, usually at concentrations well under 1%. In the skin, retinol is converted in stages to retinaldehyde and then to retinoic acid, the biologically active form that drives cell turnover and collagen signaling. That conversion also happens with prescription tretinoin (retinoic acid itself), but retinol is milder because it needs the extra conversion steps — which is part of why it's sold without a prescription.
On the carcinogenicity question, the honest answer is short: IARC has never evaluated retinol. It is absent from every one of IARC's classified-agent groups — not Group 1, not 2A, not 2B, and not even Group 3 ("not classifiable," which would still mean an evaluation happened). Regulatory — IARC Monographs — Agents Classified, Vol. 1–123 A prior internal gap-analysis pass at this Atlas flagged retinol as a carcinogen lead; that flag was wrong, and this page corrects it rather than repeats it.
How it relates to the bedroom
A bedtime product by design, not by accident
Unlike most Atlas entries, retinol's bedroom relevance isn't incidental — it's built into how the product is meant to be used. Retinol and its relatives are chemically unstable when exposed to light: they photodegrade and auto-oxidize on UV and visible-light exposure, breaking down into less-active byproducts. A 2008 pilot study measured this directly, tracking a 0.3% retinol cream (formulated with antioxidants and sunscreen filters) under simulated daily-use conditions; even with those stabilizers, retinol content dropped measurably faster when exposed to full-spectrum light than when kept dark. Peer-reviewed — Akhavan & Levitt 2008, Clin. Ther. That instability is the practical reason retinol is formulated and marketed as a night step: applying it before sleep, away from sunlight, is what keeps more of the active molecule intact and working.
Skin contact, then pillow contact
Like the Atlas's other personal-care entries, retinol reaches the bedroom the way a leave-on product does: applied to the face and neck as the last step of a routine, it doesn't fully absorb before you lie down, and some transfers onto the pillowcase and sheets over the course of the night. Inferred — leave-on skin products transfer onto bedding, consistent with the transfer pathway documented for other personal-care residues in this Atlas This is a cosmetic and laundering question, not an air-quality one — retinol is non-volatile and doesn't off-gas.
The irritation is real — and it's the actual hazard signal
Retinol's well-documented downside isn't cancer risk; it's skin irritation. A 2024 randomized, double-blind patch-test study applied retinol to healthy volunteers and reliably produced measurable irritation — redness, dryness, and barrier disruption — then tested lipid-based ingredients (a physiologic lipid mix, a specific lauroyl-glutamate compound) for their ability to blunt that response. Peer-reviewed — Fang et al. 2024, J. Cosmet. Dermatol. This irritation and temporary barrier weakening — sometimes called "retinol burn" in consumer language — is the mechanism behind the common warning that retinol users should be more careful with sun exposure the next day: not because retinol itself creates a photoreactive sensitivity, but because irritated, barrier-compromised skin sunburns more easily than intact skin.
Why regulators just tightened the concentration limits
Vitamin A is also an essential nutrient with its own dietary upper limit, and the EU's 2022 safety review was explicit that this matters: cosmetics are one more source added on top of food and supplements, and for the most-exposed slice of the population — the top 5% of consumers by vitamin A intake — that stacking could push total exposure over the safe threshold, even though the cosmetic contribution alone is comparatively small. Regulatory — EU SCCS Opinion SCCS/1639/21 That is the reasoning behind the concentration caps that took effect in the EU on 1 November 2025 (0.05% RE in body lotion, 0.3% RE elsewhere) and the new "consider your daily intake" label. It's a genuinely different kind of hazard logic than a carcinogen classification — cumulative-exposure caution for a nutrient, not evidence of a novel toxicity from the cosmetic use itself.
What the research says
- Not a classified carcinogen. Retinol has no IARC evaluation in any Group. Regulatory — IARC Monographs
- Light-unstable, which is why it's a night product. Measurable degradation under light exposure even with stabilizing antioxidants and sunscreen in the formula. Peer-reviewed — Akhavan & Levitt 2008
- Reliably irritating at effective doses. Patch testing confirms measurable irritation; certain lipid ingredients can reduce it. Peer-reviewed — Fang et al. 2024
- Regulators are managing cumulative nutrient exposure, not a new toxin. EU concentration limits respond to total vitamin A intake across diet, supplements, and cosmetics — not a novel hazard finding about retinol in skincare. Regulatory — EU SCCS
What helps reduce it
Use it as directed — at night, in small amounts. This isn't just habit; it follows the chemistry. Nighttime use avoids the light exposure that degrades the active ingredient, and starting with a lower concentration or every-other-night frequency reduces irritation while skin builds tolerance. Peer-reviewed — Akhavan & Levitt 2008
Let it absorb before you lie down. Giving a retinol product time to soak in reduces both skin irritation from occlusion and the amount that transfers onto your pillowcase. Inferred — standard leave-on product handling
Wear daytime sunscreen. Since the sun-sensitivity concern is really about irritated, barrier-weakened skin burning more easily — not a direct photoreaction — daily SPF is the actual mitigation, exactly as it is for any exfoliating or barrier-active skincare routine. Peer-reviewed — Fang et al. 2024
Launder pillowcases normally. Ordinary washing removes the skin-applied surface residue; no special treatment is indicated. Inferred
What does NOT help
- Avoiding retinol out of carcinogen fear. That specific worry has no basis in the IARC record — it was never evaluated, let alone classified. If you avoid or use retinol, base the decision on irritation tolerance and personal skin goals, not a hazard classification that doesn't exist. Regulatory — IARC Monographs
- Air purifiers or ventilation. This is a skin-and-fabric residue, not an airborne pollutant; it doesn't off-gas. Inferred
- Applying more, more often, to see faster results. Higher doses and frequency mainly increase irritation risk; the 2024 patch-test evidence points toward mitigating ingredients and gradual introduction, not simply using more. Peer-reviewed — Fang et al. 2024
Open research questions
- How much retinol or its degradation products actually transfer from a treated face onto a pillowcase over a typical night, and how that compares with the dermal dose retained in skin. Speculation
- Whether real-world (non-simulated) overnight light exposure — a phone screen, a nightlight, early dawn — meaningfully degrades retinol formulations the way full-spectrum lab lighting did in the 2008 study. Speculation
Citations
- IARC Monographs on the Identification of Carcinogenic Hazards to Humans. Agents Classified by the IARC Monographs, Volumes 1–123 (alphabetical list). Retinol / Vitamin A (CAS 68-26-8) does not appear; no IARC evaluation exists for this compound in any Group. monographs.iarc.who.int Regulatory
- EU Scientific Committee on Consumer Safety (SCCS). Revision of the scientific Opinion (SCCS/1576/16) on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate), SCCS/1639/21 (final, 24–25 October 2022). Safe at 0.05% RE in body lotion, 0.3% RE in other leave-on/rinse-off products; flags aggregate exposure for the top 5% of consumers. health.ec.europa.eu Regulatory
- Akhavan A, Levitt J (2008). Assessing retinol stability in a hydroquinone 4%/retinol 0.3% cream in the presence of antioxidants and sunscreen under simulated-use conditions: a pilot study. Clinical Therapeutics, 30(3):543–547. PMID 18405792 Peer-reviewed
- Fang Y, Ying Y, Wei X, Sun L, Xu C, Wang C, Lin D, Li Y (2024). Mitigation of retinol-induced skin irritation by physiologic lipids: Evidence from patch testing. Journal of Cosmetic Dermatology, 23(8). PMID 38628085 Peer-reviewed
Frequently asked questions
Is retinol a carcinogen?
No, and this is worth being precise about. Retinol (vitamin A, CAS 68-26-8) does not appear anywhere in IARC's list of classified agents — it is not Group 1, 2A, 2B, or 3. That is different from being "cleared": IARC has simply never evaluated it as a carcinogenicity hazard. A commonly confused fact is that IARC did evaluate nine synthetic prescription retinoid drugs (like tretinoin and etretinate, used for acne and psoriasis) for cancer-prevention potential in a 1999 Handbook — but that is a different program looking at different molecules, not retinol, and not a carcinogen classification either. Any claim that retinol carries an IARC carcinogen rating is simply wrong.
Why does retinol need to be used at night?
Because the molecule itself is unstable in light. A 2008 stability study found that a retinol cream degraded measurably faster when exposed to full-spectrum light versus kept dark, even with antioxidants and sunscreen included in the formula. Retinoids generally photodegrade and auto-oxidize on UV and visible-light exposure. Applying retinol before bed avoids direct sunlight and lets the product work overnight while the molecule is most intact — it's a formulation-chemistry reason, not primarily a sun-sensitivity reason.
Does retinol make skin more sensitive to sunlight?
Not through a true photosensitivity or phototoxic reaction — that specific mechanism has not been demonstrated for retinoids in controlled studies. What does happen is more mundane: retinol commonly causes irritation and temporary barrier disruption (dryness, flaking, redness), and irritated, barrier-compromised skin sunburns more easily. A 2024 patch-test study confirmed retinol reliably produces measurable irritation and tested lipid-based ingredients that reduce it. The practical result is the same advice either way: use retinol at night, wear sunscreen by day, and expect the irritation — not a special photoreaction — to fade as skin adjusts.
Why is a skincare ingredient in a bedroom chemistry atlas?
Because retinol is specifically a bedtime-routine product — applied to the face and neck as the last step before sleep, exactly where a pillowcase makes contact for the next seven-plus hours. Like the Atlas's other personal-care entries, it is not a mattress ingredient; it is a leave-on skin product whose residue transfers onto bedding overnight, and whose regulatory story (fresh EU concentration limits) and irritation profile are worth knowing if you use it as part of a sleep routine.
Related compounds
Embr is a sleep environment company researching and addressing the chemistry of the bedroom. Research and product development in progress.
Last reviewed 2026-07-07. If you find a factual error, contact us.